Savara

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Savara and other ETFs, options, and stocks.

About SVRA

Savara, Inc. is a clinical-stage pharmaceutical company, which engages in the development and commercialization of novel therapies for the treatment of serious or life-threatening rare respiratory diseases. Its program includes molgramostim, which is an inhaled formulation of recombinant human GM-CSF and being developed for the treatment of autoimmune pulmonary alveolar proteinosis.

CEO

Matthew Pauls

CEOMatthew Pauls

Employees

Employees59

Headquarters

Langhorne, Pennsylvania

HeadquartersLanghorne, Pennsylvania

Founded

1995

Founded1995

Employees

Employees59

SVRA Key Statistics

Market cap

414.81M

Market cap414.81M

Price-Earnings ratio

-4.84

Price-Earnings ratio-4.84

Dividend yield

—

Dividend yield—

Average volume

1.84M

Average volume1.84M

High today

$2.43

High today$2.43

Low today

$2.24

Low today$2.24

Open price

$2.29

Open price$2.29

Volume

1.08M

Volume1.08M

52 Week high

$5.11

52 Week high$5.11

52 Week low

$1.89

52 Week low$1.89

Analyst ratings

75%

of 8 ratings

Buy

75%

Hold

25%

Sell

People also own

Based on the portfolios of people who own SVRA. This list is generated using Robinhood data, and it’s not a recommendation.